MA34734B1 - Nouvelle bactérie et extraits de ladite bactérie, et leur utilisation en dermatologie - Google Patents

Nouvelle bactérie et extraits de ladite bactérie, et leur utilisation en dermatologie

Info

Publication number
MA34734B1
MA34734B1 MA36009A MA36009A MA34734B1 MA 34734 B1 MA34734 B1 MA 34734B1 MA 36009 A MA36009 A MA 36009A MA 36009 A MA36009 A MA 36009A MA 34734 B1 MA34734 B1 MA 34734B1
Authority
MA
Morocco
Prior art keywords
extracts
dermatology
bacterium
relates
novel bacteria
Prior art date
Application number
MA36009A
Other languages
English (en)
Inventor
Philippe Lebaron
Muriel Bourrain
Nathalie Castex-Rizzi
Thien Nguyen
Original Assignee
Univ Paris Curie
Centre Nat Rech Scient
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44359781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA34734(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Paris Curie, Centre Nat Rech Scient, Fabre Pierre Dermo Cosmetique filed Critical Univ Paris Curie
Publication of MA34734B1 publication Critical patent/MA34734B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne une nouvelle souche bactérienne isolée à partir de l'eau souterraine. L'invention concerne également des extraits bactériens et l'utilisation de ceux-ci dans le contexte du traitement d'inflammations. Plus particulièrement, la présente invention concerne de nouvelles compositions d'intérêt dans le traitement et la prévention de troubles inflammatoires, notamment des pathologies dermatologiques.
MA36009A 2010-12-22 2013-06-13 Nouvelle bactérie et extraits de ladite bactérie, et leur utilisation en dermatologie MA34734B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1061081A FR2969657B1 (fr) 2010-12-22 2010-12-22 Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
PCT/EP2011/073747 WO2012085182A1 (fr) 2010-12-22 2011-12-22 Nouvelle bactérie et extraits de ladite bactérie, et leur utilisation en dermatologie

Publications (1)

Publication Number Publication Date
MA34734B1 true MA34734B1 (fr) 2013-12-03

Family

ID=44359781

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36009A MA34734B1 (fr) 2010-12-22 2013-06-13 Nouvelle bactérie et extraits de ladite bactérie, et leur utilisation en dermatologie

Country Status (29)

Country Link
US (2) US9084811B2 (fr)
EP (1) EP2655595B1 (fr)
JP (2) JP6117111B2 (fr)
KR (1) KR102043472B1 (fr)
CN (1) CN103403144B (fr)
AR (1) AR084454A1 (fr)
AU (1) AU2011347254B2 (fr)
CA (1) CA2821653C (fr)
CL (1) CL2013001853A1 (fr)
CO (1) CO6741177A2 (fr)
DK (1) DK2655595T3 (fr)
ES (1) ES2689138T3 (fr)
FR (1) FR2969657B1 (fr)
GE (1) GEP201606589B (fr)
IL (1) IL226943B (fr)
MA (1) MA34734B1 (fr)
MX (1) MX345125B (fr)
MY (1) MY173066A (fr)
NZ (1) NZ612294A (fr)
PH (1) PH12013501267A1 (fr)
PL (1) PL2655595T3 (fr)
PT (1) PT2655595T (fr)
RU (1) RU2612790C2 (fr)
SG (1) SG191236A1 (fr)
TN (1) TN2013000249A1 (fr)
TW (1) TW201307551A (fr)
UA (1) UA113399C2 (fr)
WO (1) WO2012085182A1 (fr)
ZA (1) ZA201304355B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013190106A1 (fr) * 2012-06-21 2013-12-27 Pierre Fabre Medicament Utilisation d'une bactérie vivante pour le traitement de troubles intestinaux inflammatoires
AU2014326596B2 (en) 2013-09-25 2018-12-13 Vertex Pharmaceuticals Incorporated Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway
FR3065009B1 (fr) 2017-04-06 2020-11-27 Fabre Pierre Dermo Cosmetique Secretome bacterien pour son utilisation dans le traitement des lesions cutanees
FR3081705B1 (fr) 2018-06-01 2020-12-04 Fabre Pierre Dermo Cosmetique Extrait et composition dermatologique le comprenant pour le traitement des peaux sensibles
FR3114024B1 (fr) 2020-09-11 2022-09-09 Fabre Pierre Dermo Cosmetique Nouvelle émulsion mimant la peau
JP7695824B2 (ja) * 2021-06-02 2025-06-19 花王株式会社 皮膚細菌感染症の予防又は改善剤
JP7698983B2 (ja) * 2021-06-02 2025-06-26 花王株式会社 腸管感染症の予防又は改善剤
KR20260003714A (ko) * 2023-04-18 2026-01-07 삐에르화브르데르모-코스메띠끄 피부 염증 치료에 유용한 신규 세균 균주
FR3150712A1 (fr) 2023-07-06 2025-01-10 Pierre Fabre Dermo-Cosmetique Composition pour le traitement de désordres inflammatoires cutanés
FR3149774B1 (fr) 2024-01-11 2025-06-20 Fabre Pierre Dermo Cosmetique 5,6,5’,6’-tétraphényl-3,3’-(1,4-phénylène)-bis[1,2,4]triazine pour améliorer l’aspect des cicatrices et/ou réduire les marques cicatricielles

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE123417T1 (de) * 1989-10-06 1995-06-15 Janos Szabo Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen, insbesondere pyogener und atopischer dermatitis und verfahren zu deren herstellung.
CH680045A5 (fr) * 1990-02-16 1992-06-15 Om Lab Sa
EP0761204B1 (fr) * 1995-09-07 1998-04-15 L'oreal Utilisation d'un extrait d'une bactérie filamenteuse non photosynthétique et composition le contenant
AU2003239125A1 (en) * 2002-03-20 2003-10-08 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
GB0321615D0 (en) * 2003-09-15 2003-10-15 Glaxo Group Ltd Improvements in vaccination
US20050163764A1 (en) * 2003-09-22 2005-07-28 Yale University Treatment with agonists of toll-like receptors
US7244607B2 (en) * 2003-10-01 2007-07-17 The United States Of America, As Represented By The Secretary Of Agriculture Chromobacterium subtsugae sp. nov. for control of insect pests
PL2114421T3 (pl) * 2007-03-05 2018-07-31 Om Pharma Ekstrakt bakteryjny do stosowania względem zaburzeń oddechowych i sposób jego wytwarzania
FR2918883B1 (fr) * 2007-07-17 2010-01-15 Oreal Utilisation d'un extrait bacterien cultive sur une eau thermale pour le traitement des peaux seches
FR2918884B1 (fr) * 2007-07-17 2010-01-15 Oreal Utilisation d'extraits bacteriens cultives sur eau thermale comme agent anti-rougeur
FR2918885B1 (fr) * 2007-07-17 2009-08-28 Oreal Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires
JP2011519834A (ja) 2008-04-25 2011-07-14 インスティチュート フォー システムズ バイオロジー フラジェリンポリペプチドワクチン
WO2009132244A1 (fr) * 2008-04-25 2009-10-29 Id Biomedical Corporation Of Quebec Procédés de préparation de compositions immunogènes
SI22889A (sl) 2008-10-28 2010-04-30 Kemijski inštitut Himerni flagelini za cepiva
WO2010135704A2 (fr) 2009-05-22 2010-11-25 Institute For Systems Biology Protéines bactériennes associées à des sécrétions pour stimuler nlrc4
KR101762610B1 (ko) * 2010-11-05 2017-08-04 삼성전자주식회사 이동 통신 시스템에서 역방향 스케줄링 및 그를 위한 정보 전송 방법 및 장치

Also Published As

Publication number Publication date
FR2969657B1 (fr) 2014-02-07
JP6117111B2 (ja) 2017-04-19
CA2821653C (fr) 2020-03-10
AU2011347254A1 (en) 2013-07-11
CL2013001853A1 (es) 2014-03-28
JP2017099393A (ja) 2017-06-08
WO2012085182A1 (fr) 2012-06-28
GEP201606589B (en) 2017-01-10
DK2655595T3 (en) 2018-10-08
NZ612294A (en) 2015-05-29
BR112013015998A2 (pt) 2017-04-11
RU2013132895A (ru) 2015-01-27
PL2655595T3 (pl) 2019-07-31
SG191236A1 (en) 2013-07-31
US20150231187A1 (en) 2015-08-20
IL226943B (en) 2019-02-28
MX345125B (es) 2017-01-17
AR084454A1 (es) 2013-05-15
JP2014503211A (ja) 2014-02-13
CN103403144A (zh) 2013-11-20
CN103403144B (zh) 2015-11-25
TW201307551A (zh) 2013-02-16
TN2013000249A1 (en) 2014-11-10
US9662357B2 (en) 2017-05-30
AU2011347254B2 (en) 2016-07-14
UA113399C2 (xx) 2017-01-25
KR20140030109A (ko) 2014-03-11
PT2655595T (pt) 2018-11-02
ES2689138T3 (es) 2018-11-08
CO6741177A2 (es) 2013-08-30
EP2655595B1 (fr) 2018-07-04
KR102043472B1 (ko) 2019-11-11
CA2821653A1 (fr) 2012-06-28
MY173066A (en) 2019-12-23
RU2612790C2 (ru) 2017-03-13
FR2969657A1 (fr) 2012-06-29
HK1187366A1 (zh) 2014-04-04
EP2655595A1 (fr) 2013-10-30
ZA201304355B (en) 2014-11-26
PH12013501267A1 (en) 2013-08-28
MX2013007217A (es) 2014-01-08
US9084811B2 (en) 2015-07-21
US20130316033A1 (en) 2013-11-28

Similar Documents

Publication Publication Date Title
TN2013000249A1 (en) Novel bacterium and extracts of said bacterium and the use of same in dermatology
TN2010000068A1 (en) Anticorps anti-cd37
MA33155B1 (fr) Composes organiques et leurs utilisations
MA34831B1 (fr) Amides d'aminoindanes presentant une forte activite fongicide et leurs compositions phytosanitaires
EA201270824A1 (ru) Соединения для уменьшения продукции бета-амилоида
EP2536406A4 (fr) Bismuth-thiols comme antiseptiques destinés à des utilisations biomédicales, comprenant le traitement de biofilms bactériens et d'autres utilisations
MA44674B1 (fr) Inhibiteurs de bromodomaine
MA41060B1 (fr) Compositions comprenant des souches bactériennes
MA55434B1 (fr) Compositions comprenant des souches bactériennes
MA47440B1 (fr) Sulfonylurées, composés apparentés, et leur utilisation
MA34248B1 (fr) 5-fluoro-1h-pyrazolopyridines substituées et leur utilisation
MA31667B1 (fr) Induction dun phenotype tolerogene dans des cellules dendritiques matures
MA35365B1 (fr) Pyrimidines annelées substituées et leur utilisation
TN2009000551A1 (fr) Nouveaux composes chimiques
MA34057B1 (fr) Compositions et methodes pour le diagnostic et le traitement d'une tumeur
MA33349B1 (fr) Compositions pharmaceutiques solides et procedes pour leur production
ATE440117T1 (de) Polymermicellen für die arzneistoffzufuhr
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
WO2011022357A3 (fr) Enzymes de clivage de snare à action rapide
MA31263B1 (fr) Composition d'acariens
FR2959128B1 (fr) Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement des odeurs corporelles
MA35895B1 (fr) Inhibiteurs d'iap
FR3052668B1 (fr) Extrait de cellules indifferenciees de mimosa pudica et ses utilisations en dermo cosmetique
MA35457B1 (fr) Nouvelles formulations de pyriméthanil et leur utilisations dans le traitement des cultures
MA32158B1 (fr) Thiazolyldihydroindazoles